phenylalanine has been researched along with Colicky Pain in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (83.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Groff, A; Jain, R; Packard, E; Shahid, Z | 1 |
| Andrae, DA; Covington, PS; Dove, LS; Lembo, AJ | 1 |
| Benson, AB; Dharba, S; Joish, VN; Lapuerta, P; Sapre, D; Strosberg, J | 1 |
| Cash, BD; Chey, WD; Covington, PS; Dove, LS; Lacy, BE; Lembo, AJ | 1 |
| Banks, P; Caplin, M; Fleming, D; Hörsch, D; Lapuerta, P; Pavel, M; Ramage, J; Sands, A; Seufferlein, T; Valle, J; Wiedenmann, B; Zambrowicz, B | 1 |
| Cash, BD; Earnest, DL; Lacy, BE; Rao, T | 1 |
| Andrae, DA; Covington, PS; Davenport, JM; Dove, LS; Lacy, BE; Lembo, AJ; Lopez, R; McIntyre, G; Schey, R; Turner, L; Zuckerman, MJ | 1 |
| Abenavoli, L; Gasbarrini, A; Ianiro, G; Laterza, L; Scarpellini, E; Tack, J | 1 |
| Talley, NJ | 1 |
| Cash, BD; Covington, PS; Dove, LS; Lacy, BE; Schoenfeld, PS | 1 |
| Boeckxstaens, G; Camilleri, M | 1 |
| Bronner, J; Brown, PM; Cline, GA; Drossman, DA; Frazier, KS; Freiman, J; Gershon, MD; Jackson, JI; Sands, A; Wood, AJ; Zambrowicz, B | 1 |
3 review(s) available for phenylalanine and Colicky Pain
| Article | Year |
|---|---|
Rifaximin and eluxadoline - newly approved treatments for diarrhea-predominant irritable bowel syndrome: what is their role in clinical practice alongside alosetron?
Topics: Abdominal Pain; Anti-Bacterial Agents; Carbolines; Diarrhea; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Narcotic Antagonists; Phenylalanine; Receptors, Opioid; Rifamycins; Rifaximin; Serotonin 5-HT3 Receptor Antagonists | 2016 |
Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome.
Topics: Abdominal Pain; Constipation; Diarrhea; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Imidazoles; Irritable Bowel Syndrome; Phenylalanine; Receptors, Opioid | 2016 |
Dietary and pharmacological treatment of abdominal pain in IBS.
Topics: Abdominal Pain; Anti-Infective Agents; Antidepressive Agents; Butyrophenones; Dipeptides; GABA Agents; Gastrointestinal Agents; Histamine H1 Antagonists; Humans; Imidazoles; Irritable Bowel Syndrome; Mentha piperita; Parasympatholytics; Phenylalanine; Piperidines; Plant Oils; Probiotics; Quaternary Ammonium Compounds; Rifamycins; Rifaximin; Serotonin 5-HT3 Receptor Antagonists; Thiophenes; Visceral Pain | 2017 |
6 trial(s) available for phenylalanine and Colicky Pain
| Article | Year |
|---|---|
Effects of treatment with eluxadoline on abdominal pain in patients with IBS-D: Additional post hoc analyses of Phase 3 trials.
Topics: Abdominal Pain; Adult; Aged; Diarrhea; Double-Blind Method; Female; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Male; Middle Aged; Phenylalanine; Treatment Outcome | 2020 |
Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use.
Topics: Abdominal Pain; Adult; Antidiarrheals; Diarrhea; Double-Blind Method; Female; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Loperamide; Male; Middle Aged; Pain Measurement; Phenylalanine; Symptom Assessment | 2017 |
Telotristat etiprate for carcinoid syndrome: a single-arm, multicenter trial.
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Female; Flushing; Gastrointestinal Transit; Humans; Hydroxyindoleacetic Acid; Male; Malignant Carcinoid Syndrome; Middle Aged; Phenylalanine; Pyrimidines; Treatment Outcome | 2015 |
Eluxadoline for Irritable Bowel Syndrome with Diarrhea.
Topics: Abdominal Pain; Adult; Aged; Diarrhea; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; Irritable Bowel Syndrome; Male; Middle Aged; Pancreatitis; Phenylalanine | 2016 |
Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea.
Topics: Abdominal Pain; Adult; Aged; Constipation; Diarrhea; Double-Blind Method; Female; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Male; Middle Aged; Nausea; Pancreatitis; Phenylalanine; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Spasm; Sphincter of Oddi Dysfunction | 2017 |
The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome.
Topics: Abdominal Pain; Adult; Biomarkers; Biphenyl Compounds; Constipation; Double-Blind Method; Feces; Female; Humans; Hydroxyindoleacetic Acid; Irritable Bowel Syndrome; Male; Middle Aged; Pain Measurement; Phenylalanine; Serotonin; Severity of Illness Index; Tryptophan Hydroxylase | 2011 |
3 other study(ies) available for phenylalanine and Colicky Pain
| Article | Year |
|---|---|
Eluxadoline-induced pancreatitis occurring in an adult man without a prior cholecystectomy.
Topics: Abdominal Pain; Humans; Imidazoles; Male; Middle Aged; Pancreatitis; Phenylalanine | 2019 |
Clinical Benefits of Telotristat Ethyl in Patients With Neuroendocrine Tumors and Low Bowel Movement Frequency: An Observational Patient-Reported Outcomes Study.
Topics: Abdominal Pain; Adolescent; Adult; Aged; Child; Child, Preschool; Defecation; Diarrhea; Female; Flushing; Humans; Infant; Infant, Newborn; Male; Malignant Carcinoid Syndrome; Middle Aged; Nausea; Patient Reported Outcome Measures; Phenylalanine; Pyrimidines; Recovery of Function; Time Factors; Treatment Outcome; Young Adult | 2020 |
Board Review Vignette: Irritable Bowel Syndrome.
Topics: Abdominal Pain; Adult; Anion Exchange Resins; Antidiarrheals; Carbolines; Cholestyramine Resin; Constipation; Diarrhea; Disease Management; Female; Gastrointestinal Agents; Guanylyl Cyclase C Agonists; Humans; Imidazoles; Irritable Bowel Syndrome; Laxatives; Loperamide; Peptides; Phenylalanine; Probiotics; Rifamycins; Rifaximin; Selective Serotonin Reuptake Inhibitors | 2016 |